<Advanced Viral Research Corp> said its facility to manufacture reticulose, an anti- viral agent, is ready for FDA inspection. The company said it will make a formal request for the review by the end of March. The company said if the facility is approved, initial tests and trials on AIDS patients will start soon afterward. 